NeuroRX
-
Private Investors Buy $25M in NRx Stock for Radnor Firm’s COVID Research
Undisclosed investors are purchasing 7.8 million shares of NRx Pharmaceutical stock, raising $25 million to finance the Radnor company’s development of therapy and a vaccine…
-
NeuroX in Radnor Tests Older Drug That Could Prevent COVID-19 Respiratory Failure
NeuroRX in Radnor and Wilmington is revitalizing a drug shelved 20 years ago that now shows promise in preventing respiratory failure for patients with COVID-19,…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
